Mount Sinai Announces Collaborative Research Agreement to Evaluate Novel Liquid Radioembolic Agent for Brain Tumors
September 28, 2026
September 28, 2026
NEW YORK, Sept. 28 [Category: BizHospital] -- Mount Sinai Health System posted the following news release:
* * *
Mount Sinai Announces Collaborative Research Agreement to Evaluate Novel Liquid Radioembolic Agent for Brain Tumors
*
The Icahn School of Medicine at Mount Sinai today announced a collaborative research agreement with Johnson & Johnson[1] to evaluate an investigational liquid radioembolic agent designed to deliver targeted radiat . . .
* * *
Mount Sinai Announces Collaborative Research Agreement to Evaluate Novel Liquid Radioembolic Agent for Brain Tumors
*
The Icahn School of Medicine at Mount Sinai today announced a collaborative research agreement with Johnson & Johnson[1] to evaluate an investigational liquid radioembolic agent designed to deliver targeted radiat . . .